Category: csl

Australia Inks Next-Gen mRNA Technology Deal With US

November 2, 2022
AmericasAustraliaCCP ViruscslmRNA vaccineScienceScience NewsVaccines & SafetyWorld
0 Comment

Commonwealth Serum Laboratories (CSL), an Australian biotechnology company and the world’s second-biggest flu vaccine manufacturer, has agreed to pay $312 million ($US200 million) to use groundbreaking mRNA vaccine technology from a U.S. company. The vaccine manufacturer announced on Nov. 2 that it had licenced the new technology with Arcturus Therapeutics, an American mRNA medicines biotechnology company….

Read More

Australian University to Collaborate with Moderna for mRNA Vaccine Research

March 10, 2022
AustraliaCCP VirusCOVID-19 vaccinecslMark WalkerModernamRNA technologyNikolai PetrovskyScienceScience NewsUniversity of QueenslandVaccines & SafetyWorld
0 Comment

The University of Queensland announced its collaboration with Moderna to use mRNA research for vaccine development of diseases that pose risks of causing future pandemics. The university previously collaborated with CSL—a major biotechnology firm now responsible for the manufacturing of the AstraZeneca vaccine in Australia—on producing a COVID-19 vaccine. The deal was called off, however,…

Read More

Australia Approves First Cell-Based Flu Vaccines For Kids Aged Two and Older

March 8, 2022
AustraliacellCOVID-19 vaccinecslInfluenzaInfluenza vaccineWorld
0 Comment

The first cell-based Influenza vaccine in Australia has been approved for use in adults and children aged two years and older. In a statement written to the Epoch Times, the Therapeutic Goods Administration (TGA) wrote that the Flucelvax Quad vaccine is the first and only cell-based flu vaccine available in Australia and approved for Australians…

Read More